Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate in the following upcoming investor conferences:
Event: Stifel Nicolaus Healthcare Conference Date: Thursday, September 16, 2010 Time: 10:20 a.m. ET Location: Four Seasons Hotel 200 Boylston Street Boston, Mass. Speaker: Gearoid Faherty, Chairman and Chief Executive Officer Event: UBS Global Life Sciences Conference Date: Monday, September 20, 2010 Time: 9:00 a.m. ET Location: Grand Hyatt Hotel Park Avenue at Grand Central New York, N.Y. Speaker: John Fraher, Chief Commercial Officer
An audio webcast of the Company's presentations at each conference will be available by accessing the investor relations section of www.eurand.com (http://www.eurand.com) and will be available via replay for 30 days following the date of the presentation.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com (http://www.eurand.com) .
